April 03, 2025

Study Reveals Psychiatric Sequelae Post-COVID-19

COVID-19 survivors showed a significantly higher risk of psychiatric disorders, according to a recent study.

Conexiant

April 03, 2025

Lung Screening Lags Despite Cancer Prevention Uptake

Eligible patients undergo breast and colorectal cancer screenings at nearly four times the rate of recommended lung cancer screening, revealing significant intervention opportunities, according to a new JAMA study.

Conexiant

April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant

April 02, 2025

Maternal Depression Affects Child's Eating Patterns

Early maternal depressive symptoms may hinder children's self-regulation and eating behaviors, according to a recent study.

Conexiant

April 02, 2025

Donanemab: Amyloid-Related Imaging Abnormalities

"ARIA is an adverse event associated with donanemab treatment that requires safety monitoring."

Conexiant

April 02, 2025

New Antibody Lowers COVID-19 Cases in Trial

Sipavibart reduced symptomatic COVID-19 by 34.9% compared to standard treatment, but efficacy was only observed against non–Phe456Leu-containing variants, according to new phase 3 trial data.

Conexiant

April 02, 2025

Do NSAIDs Prevent Dementia?

Long-term anti-inflammatory use linked to 12% reduced dementia risk in 14-year population study.

Conexiant

April 02, 2025

Sleep Apnea Associated with Lung Cancer Risk

The impact of sleep apnea on lung cancer risk appears to be strongly influenced by biological sex, researchers find in a nationwide study of COPD patients.

Conexiant

April 02, 2025

GLP-1 Spending Surged 500% Since 2018

U.S. spending on GLP-1 receptor agonists reached $71.7 billion in 2023. Semaglutide and tirzepatide products have captured 70% of the market as diabetes and weight loss medication use rapidly expands, according to new research.

Conexiant